Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Repligen Company Profile (NASDAQ:RGEN)

Consensus Ratings for Repligen (NASDAQ:RGEN) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.50 (12.24% upside)

Analysts' Ratings History for Repligen (NASDAQ:RGEN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/17/2014Jefferies GroupReiterated RatingBuy$22.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
6/26/2014Janney Montgomery ScottInitiated CoverageBuy -> Buy$26.00ViewTweet This Rating  Share This Rating on StockTwits
6/4/2014Jefferies GroupBoost Price TargetBuy$20.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2014Jefferies GroupInitiated CoverageBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
3/8/2013StephensInitiated CoverageOverweight$10.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/22/2012 forward)
Discuss Repligen